The impact of obesity on liver histology

Clinics in Liver Disease

Volumn 18, Issue 1, 2014, Pages 33-40

  Goodman, Zachary D ^a  

^a INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Cryptogenic cirrhosis; Hepatocellular adenoma; Hepatocellular carcinoma; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Steatosis

Indexed keywords

CANCER INCIDENCE; DIABETIC PATIENT; DIAGNOSTIC PROCEDURE; FATTY LIVER; HISTOLOGY; HUMAN; LIVER ADENOMA; LIVER BIOPSY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; REVIEW;

CRYPTOGENIC CIRRHOSIS; HEPATOCELLULAR ADENOMA; HEPATOCELLULAR CARCINOMA; NONALCOHOLIC FATTY LIVER DISEASE; NONALCOHOLIC STEATOHEPATITIS; STEATOSIS;

ADENOMA, LIVER CELL; CARCINOMA, HEPATOCELLULAR; ENERGY METABOLISM; FATTY LIVER; HUMANS; LIPID METABOLISM; LIVER; LIVER DISEASES; LIVER NEOPLASMS; METABOLIC SYNDROME X; OBESITY;

EID: 84888023568     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2013.09.010     Document Type: Review

References (32)

1. Phillips M.J., Poucell S., Patterson J., et al. The Liver: an atlas and text of ultrastructural pathology 1987, Raven Press, New York.
2. Fraser J.L., Antonioli D.A., Chopra S., et al. Prevalence and nonspecificity of microvesicular fatty change in the liver. Mod Pathol 1995, 8:65-70.
3. Bonnell H.J., Beckwith J.B. Fatty liver in sudden childhood death. Am J Dis Child 1986, 140:30-33.
4. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
5. Burt A.D., Mutton A., Day C.P. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998, 15:246-258.
6. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
7. Hall A.R., Dhillon A.P., Green A.C., et al. Hepatic steatosis estimated microscopically versus digital image analysis. Liver Int 2013, 33:926-935.
8. Poynard T., Ratziu V., McHutchison J., et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003, 38:75-85.
9. Conjeevaram H.S., Kleiner D.E., Everhart J.E., et al. Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology 2007, 45:80-87.
10. Dixon J.B., Bhathal P.S., O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91-100.
11. Marceau P., Biron S., Hould F.S., et al. Liver pathology and the metabolic syndrome X in severe obesity. JClin Endocrinol Metab 1999, 84:1513-1517.
12. Bugianesi E., McCullough A.J., Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005, 42:987-1000.
13. Hooper A.J., Adams L.A., Burnett J.R. Genetic determinants of hepatic steatosis in man. JLipid Res 2011, 52:593-617.
14. Day C.P. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002, 16:663-678.
15. Adler M., Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979, 67:811-816.
16. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55:434-438.
17. Falchuk K.R., Fiske S.C., Haggitt R.C., et al. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology 1980, 78:535-541.
18. Lackner C., Gogg-Kamerer M., Zatloukal K., et al. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. JHepatol 2008, 48:821-828.
19. Skoien R., Richardson M.M., Jonsson J.R., et al. Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Liver Int 2013, 33:624-632.
20. Brunt E.M., Kleiner D.E., Wilson L.A., et al. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009, 49:809-820.
21. Neuschwander-Tetri B.A., Clark J.M., Bass N.M., et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010, 52:913-924.
22. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990, 12:1106-1110.
23. Caldwell S.H., Oelsner D.H., Iezzoni J.C., et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999, 29:664-669.
24. Caldwell S.H., Crespo D.M. The spectrum expanded: cryptogenic cirrhosis and the natural history of nonalcoholic fatty liver disease. JHepatol 2004, 40:578-584.
25. van der Poorten D., Samer C.F., Ramezani-Moghadam M., et al. Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?. Hepatology 2013, 57:2180-2188.
26. Paradis V., Champault A., Ronot M., et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007, 46:140-146.
27. Biolulac-Sage P., Taouji S., Possenti L., et al. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int 2012, 32:1217-1221.
28. Paradis V., Zalinski S., Chelbi E., et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009, 49:851-859.
29. Larsson S.C., Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007, 97:1005-1008.
30. El-Serag H.B., Hampel H., Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006, 4:369-380.
31. White D.L., Kanwal F., El-Serag H.B. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012, 10:1342-1359.
32. Baffy G., Brunt E.M., Caldwell S.H. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. JHepatol 2012, 56:1384-1391.